Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LNG vs GSK✓SelectedUSD · GSKLNG vs GSK performance historyLatest closeAs of-1.81%11/18
Stock and ETF performance explorer

LNG vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,201.4%
GSK return
+1,058.9%
Excess return
+142.5%
Maximum drawdown
-98.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-1.3%-0.5%-1.4%
7D-2.6%-3.1%+0.5%-1.7%
30D+3.7%-0.9%+4.6%+3.8%
3M+8.5%-4.2%+12.7%+9.5%
6M+20.2%-1.6%+21.8%+19.9%
YTD+54.0%+2.6%+51.4%+50.1%
1Y+40.9%+6.2%+34.7%+35.7%
3Y+75.9%+55.0%+20.9%+46.1%
5Y+190.4%+42.8%+147.6%+143.3%
10Y+712.3%+102.1%+610.2%+491.7%
All+1,201.4%+1,058.9%+142.5%+961.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling